Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
10/17/2001 | CN1318090A Process for prepn. of substituted amido phthalocyanine derivatives and substituted amido phthlocyanine derivatives |
10/17/2001 | CN1073112C Possibly substituted 8-cyano-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives |
10/16/2001 | US6303814 N-[1,2,4]triazoloazinyl) benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides |
10/16/2001 | US6303626 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound |
10/16/2001 | US6303614 Tetrahydro gamma-carbolines |
10/16/2001 | US6303605 For therapy of anxiety and convulsions |
10/16/2001 | US6303604 Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase |
10/16/2001 | US6303597 For therapy of anxiety and convulsions |
10/16/2001 | US6303238 OLEDs doped with phosphorescent compounds |
10/16/2001 | CA2036977C Imidazopyridazines, their production and use |
10/16/2001 | CA2017115C Poly(oxyalkylene) modified phthalocyanine colorants |
10/11/2001 | WO2001074821A1 Novel process for producing fused imidazopyridine derivative and novel crystal form |
10/11/2001 | WO2001074820A1 Novel derivatives and analogues of galanthamin |
10/11/2001 | WO2001074818A1 Chlorins with fused rings for use in photodynamic therapy |
10/11/2001 | WO2001074817A1 Hydrazide derivatives |
10/11/2001 | WO2001074788A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
10/11/2001 | WO2001074774A1 Ethylenediamine derivatives |
10/11/2001 | WO2001074741A2 Catalytic asymmetric desymmetrization of meso compounds |
10/11/2001 | WO2001074398A1 Photodynamic therapy compounds |
10/11/2001 | WO2001027119A3 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
10/11/2001 | WO2001019826A3 Triazolopyrimidine derivatives |
10/11/2001 | WO2001003126A3 High density non-volatile memory device |
10/11/2001 | CA2405535A1 Catalytic asymmetric desymmetrization of meso compounds |
10/11/2001 | CA2405144A1 Ethylenediamine derivatives |
10/11/2001 | CA2405132A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
10/11/2001 | CA2403131A1 Novel process for producing fused imidazopyridine derivative and novel crystal form |
10/11/2001 | CA2376001A1 Photodynamic therapy compounds |
10/11/2001 | CA2368966A1 New derivatives and analogues of galanthamine |
10/10/2001 | EP1142893A1 Substituted O6-benzylguanines and 6(4)-benzyloxypyrimidines |
10/10/2001 | EP1141142A1 Improved method for producing thermally cleavable, soluble pigment derivatives |
10/10/2001 | EP1141140A1 Naphthalenehydrazamimides and perylenehydrazamimides |
10/10/2001 | EP1140946A2 Quinoline derivatives |
10/10/2001 | EP1140943A2 Substituted pyrroloindoles |
10/10/2001 | EP1140942A2 Prenyl transferase inhibitors |
10/10/2001 | EP1140941A1 Nitrogen containing heterobicycles as factor xa inhibitors |
10/10/2001 | EP1140940A1 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)qinoxalin-5(6h)one derivates being 5ht2c agonists |
10/10/2001 | EP1140939A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods |
10/10/2001 | EP1140938A2 High affinity inhibitors for target validation and uses thereof |
10/10/2001 | EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
10/10/2001 | EP1140935A2 1,2-annelated quinoline derivatives |
10/10/2001 | EP1140931A1 5ht1 antagonists for antidepressant therapy |
10/10/2001 | EP1140914A1 Non-peptide nk1 receptors antagonists |
10/10/2001 | EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
10/10/2001 | EP1140827A1 Synthesis of phenolic monomers containing imide or diimide moieties and high heat carbonate polymers prepared therefrom |
10/10/2001 | EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
10/10/2001 | EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
10/10/2001 | EP1140085A1 Azabicycloalkanes as ccr5 modulators |
10/10/2001 | CN1316418A Benzene sulfonic derivative |
10/09/2001 | US6300498 Substituted ammonium salt of 1,5′-bitetrazole |
10/09/2001 | US6300335 Urogenital disorders |
10/09/2001 | CA2016501C Substituted pyrrole compounds and their applications in pharmacy |
10/04/2001 | WO2001073438A1 Ricin inhibitors and methods for use thereof |
10/04/2001 | WO2001072752A2 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS |
10/04/2001 | WO2001072751A1 Pyrrolopyrimidines as tyrosine kinase inhibitors |
10/04/2001 | WO2001072718A1 Pharmaceutical compositions containing as the active ingredient nitropyrimidine derivatives or salts thereof |
10/04/2001 | WO2001072696A1 Arthropodicidal carboxanilides |
10/04/2001 | WO2001072667A2 Modifying chemoselectivity during oxidation of nitrogen compounds |
10/04/2001 | WO2001019828A3 Kinase inhibitors as therapeutic agents |
10/04/2001 | US20010027253 Photoactivatable nitrogen-containing bases based on alpha-amino ketones |
10/04/2001 | US20010027252 Novel mercapto-substitued imidazolylporphyrin metal complex monomer, polymer having the same as a repeating unit and method of preparing the same |
10/04/2001 | US20010027197 Antiproliverative, -carcinogenic and -tumor agents; mitogenesis-activated protein kinase inhibitors; noncytotoxic; binding with high affinity at the adenosine triphosphate binding site of the kinases |
10/04/2001 | EP1139170A2 Silver halide color photographic light-sensitive material, pyrrolotriazole compound and dye-forming compound |
10/04/2001 | EP1137739A1 Catalytic cracking process using an mcm-68 catalyst |
10/04/2001 | EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors |
10/04/2001 | EP1137411A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
10/04/2001 | EP0973395A4 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them |
10/04/2001 | EP0851898B1 Low hue photobleaches |
10/04/2001 | EP0815123B1 Beta-sheet mimetics and use thereof as protease inhibitors |
10/04/2001 | EP0757673B1 Heterocyclylbenzonitriles |
10/04/2001 | EP0730581B1 3-acylaminobenzazepines |
10/04/2001 | EP0552329B1 Methylen-oxindole derivatives and process for their preparation |
10/04/2001 | EP0529002B1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
10/04/2001 | CA2404392A1 Modifying chemoselectivity during oxidation of nitrogen compounds |
10/04/2001 | CA2402472A1 2,3,4,5-tetrahydro-1h-¬1,4|diazepino¬1,7a|indole compounds |
10/03/2001 | CN1315953A Process for preparation of imidazodiazepine intermediates |
10/03/2001 | CN1315945A Nitrate salts of antihypertensive medicines |
10/02/2001 | US6297380 Process and intermediates for growth hormone secretagogues |
10/02/2001 | US6297373 Method for acylating hexakis (arylmethyl) hexaazaisowurtzitane |
10/02/2001 | US6297372 Process for the preparation of hexanitrohexaazaisowurtzitanes |
10/02/2001 | US6297252 Treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs, and enhancement of memory. |
10/02/2001 | US6297251 Fungicidal trifluorophenyl-triazolopyrimidines |
10/02/2001 | US6297250 Useful for inhibiting transport of nucleosides or purines across cell membranes, thereby to potentiate the activity of various cytotoxic antitumor drugs |
10/02/2001 | US6297235 Triazolopyridazine derivatives for treating anxiety and enhancing cognition |
10/02/2001 | US6297234 Arylthiophene vasopressin agonists |
10/02/2001 | US6297232 Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments |
10/02/2001 | US6297207 Photochemical singlet oxygen generations having enhanced singlet oxygen yields |
10/02/2001 | US6297195 Componds with thiophene aryl groups for herbicides, plant growth regulators and nematocides |
10/02/2001 | CA2037541C Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
09/27/2001 | WO2001070744A2 Process for the preparation of midazolam |
09/27/2001 | WO2001070743A1 Non-amidine containing protease inhibitors |
09/27/2001 | WO2001070731A1 Decahydro-isoquinolines |
09/27/2001 | WO2001070708A1 Substituted piperidines as melanocortin receptor agonists |
09/27/2001 | WO2001070695A1 Pyridine derivatives as inhibitors of p38 |
09/27/2001 | WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
09/27/2001 | WO2001019829A3 Pyrazolopyrimidines as therapeutic agents |
09/27/2001 | WO2001017972A3 Novel herbicides |
09/27/2001 | WO2001013895A3 Controlled-release sedative-hypnotic compositions and methods related thereto |
09/27/2001 | US20010025047 Nitrogen containing bicyclic heteroaromatic compound containing sulfonamide and hydroxyamide groups, useful in treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, bone disease and HIV infections |
09/27/2001 | US20010025042 A fused nitrogen containing heterocyclic compound useful for treating psychiatric and neurological disorders, anxiety, post-traumatic stress, supranuclear palsy, feeding, immunological, cardiovascular and hypersensitivity disorders |
09/27/2001 | US20010025039 Tricyclic aza-indolyl derivatives substituted with ethylamine group is useful for treating central nervous system disorder,cardiovascular disorder, gastrointestinal disorders, diabetes insipidus, and particularly useful for obesity |